Overexpression of p53 and HER-2/neu Proteins as Prognostic Markers in Early Stage Breast Cancer
Jeffrey R. Marks(Duke University), J. Dirk Iglehart(Brigham and Women's Hospital), Katherine Wu(Memorial Sloan Kettering Cancer Center), Billie‐Jo M. Kerns(Duke Medical Center), Nicholas Bandarenko(Duke Medical Center), Donald A. Berry(The University of Texas MD Anderson Cancer Center), Peter A. Humphrey(Jewish Hospital)
Cited by 112
Related Papers
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k
A Python library for probabilistic analysis of single-cell omics data
|Nature Biotechnology|2022|809
Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents
|Cancer Discovery|2012|684
Emergence of a High-Plasticity Cell State during Lung Cancer Evolution
|Cancer Cell|2020|398